De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary percutaneous coronary intervention may benefit stable patients with a lower BMI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback